Article
Hsp90: A Global Regulator of the Genotype-to-Phenotype Map in Cancers.
Advances in cancer research - 1 Jan 2016
Jarosz Daniel
Abstract excerpt
Cancer cells have the unusual capacity to limit the cost of the mutation load that they harbor and simultaneously harness its evolutionary potential. This property fuels drug resistance, a key failure mode in oncogene-directed therapy. However, the factors that regulate this capacity might also provide an Achilles' heel that could be exploited therapeutically. Recently, insight has come from a seemingly distant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
